Please use this identifier to cite or link to this item: https://ir.swu.ac.th/jspui/handle/123456789/13699
Full metadata record
DC FieldValueLanguage
dc.contributor.authorTalungchit S.
dc.contributor.authorBuajeeb W.
dc.contributor.authorLerdtripop C.
dc.contributor.authorSurarit R.
dc.contributor.authorChairatvit K.
dc.contributor.authorRoytrakul S.
dc.contributor.authorKobayashi H.
dc.contributor.authorIzumi Y.
dc.contributor.authorKhovidhunkit S.-O.P.
dc.date.accessioned2021-04-05T03:25:49Z-
dc.date.available2021-04-05T03:25:49Z-
dc.date.issued2018
dc.identifier.issn14726831
dc.identifier.other2-s2.0-85043468446
dc.identifier.urihttps://ir.swu.ac.th/jspui/handle/123456789/13699-
dc.identifier.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85043468446&doi=10.1186%2fs12903-018-0504-8&partnerID=40&md5=63173c19dd6b0abe6a6b49174b02ed10
dc.description.abstractBackground: Salivary protein biomarkers for screening and diagnosis of oral lichen planus (OLP) are not well-defined. The objective of this study was to identify putative protein biomarkers for OLP using proteomic approaches. Methods: Pooled unstimulated whole saliva was collected from five OLP patients and five healthy control participants. Saliva samples were then subjected to two-dimensional gel electrophoresis, followed by mass spectrometry to identify putative protein biomarkers. Subsequently, a subset of these putative biomarkers were validated in 24 OLP patients and 24 age-matched healthy control subjects, using an enzyme-linked immunosorbent assay (ELISA). Immunoblotting analyses were then performed in 3 pairs of age- and sex-matched OLP patients and healthy controls to confirm results from the ELISA study. Results: Thirty-one protein spots were identified, corresponding to 20 unique proteins. Notably, fibrinogen fragment D and complement component C3c exhibited increased expression in OLP patients, while cystatin SA exhibited decreased expression in OLP patients, compared with healthy control subjects. ELISA analyses indicated increased expression of fibrinogen fragment D and complement component C3c, and decreased expression of cystatin SA, in the saliva of OLP patients. Statistical differences in the expression of salivary complement C3c were observed between OLP patients and healthy control subjects. Immunoblotting analyses confirmed the results of our ELISA study. Conclusion: Complement C3c, fibrinogen fragment D and cystatin SA may serve as salivary biomarkers for screening and/or diagnosis of OLP. © 2018 The Author(s).
dc.subjectbiological marker
dc.subjectcomplement component C3c
dc.subjectcystatin S
dc.subjectfibrin degradation product
dc.subjectfibrinogen D fragment
dc.subjectprotein
dc.subjectadult
dc.subjectaged
dc.subjectcase control study
dc.subjectchemistry
dc.subjectenzyme linked immunosorbent assay
dc.subjectfemale
dc.subjecthuman
dc.subjectimmunoblotting
dc.subjectlichen planus
dc.subjectmale
dc.subjectmass spectrometry
dc.subjectmiddle aged
dc.subjectproteomics
dc.subjectsaliva
dc.subjecttwo dimensional gel electrophoresis
dc.subjectAdult
dc.subjectAged
dc.subjectBiomarkers
dc.subjectCase-Control Studies
dc.subjectComplement C3c
dc.subjectElectrophoresis, Gel, Two-Dimensional
dc.subjectEnzyme-Linked Immunosorbent Assay
dc.subjectFemale
dc.subjectFibrin Fibrinogen Degradation Products
dc.subjectHumans
dc.subjectImmunoblotting
dc.subjectLichen Planus, Oral
dc.subjectMale
dc.subjectMass Spectrometry
dc.subjectMiddle Aged
dc.subjectProteins
dc.subjectProteomics
dc.subjectSaliva
dc.subjectSalivary Cystatins
dc.titlePutative salivary protein biomarkers for the diagnosis of oral lichen planus: A case-control study
dc.typeArticle
dc.rights.holderScopus
dc.identifier.bibliograpycitationBMC Oral Health. Vol 18, No.1 (2018)
dc.identifier.doi10.1186/s12903-018-0504-8
Appears in Collections:Scopus 1983-2021

Files in This Item:
There are no files associated with this item.


Items in SWU repository are protected by copyright, with all rights reserved, unless otherwise indicated.